Literature DB >> 28850958

Quality Standards for Herbal Drugs and Herbal Drug Preparations - Appropriate or Improvements Necessary?

Reinhard Länger1, Erich Stöger2, Wolfgang Kubelka3, Keith Helliwell4.   

Abstract

Standards for quality control as defined in the European Pharmacopoeia contribute significantly to a consistent and high quality of herbal drugs, herbal drug preparations, and herbal medicinal products. The minimum content of single plant constituents is considered of high relevance. Therefore, nearly all monographs on herbal drugs or herbal drug preparations contain an obligatory assay.However, a critical evaluation of the data published for such assayed constituents reveals that in most cases these constituents have to be considered as purely analytical markers without correlation to quality or efficacy. Examples where the assay does not meet its objective support the need to adapt current quality standards. Moreover, the trend to increase the content of certain constituents may lead to significant modifications to traditional manufacturing processes.In order to initiate a scientific discussion, the role of the assay in the context of quality requirements, quality documentation in the manufacturing process, safety, and efficacy is discussed and possible alternatives to the single marker assay are examined. Georg Thieme Verlag KG Stuttgart · New York.

Mesh:

Substances:

Year:  2017        PMID: 28850958     DOI: 10.1055/s-0043-118534

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  2 in total

1.  Study on the Spectrum-Effect Relationship of the Traditional Effect of Saponins in Glycyrrhiza uralensis Fisch.

Authors:  Wenxin Xia; Qiansong Liu; Hao Zhou; Shiyao Hua; Lin Dong; Xuebo Han; Xueyan Fu
Journal:  Int J Anal Chem       Date:  2021-03-16       Impact factor: 1.885

Review 2.  Advances in Fingerprint Analysis for Standardization and Quality Control of Herbal Medicines.

Authors:  Eka Noviana; Gunawan Indrayanto; Abdul Rohman
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.